Samidh Shah
Overview
Explore the profile of Samidh Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A, et al.
Indian J Med Res
. 2025 Feb;
160(6):637-638.
PMID: 39913524
No abstract available.
2.
Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A, et al.
Indian J Med Res
. 2024 Mar;
159(2):130-141.
PMID: 38528817
Background Objectives: Irrational prescribing practices have major consequences on patient safety and also increase the economic burden. Real-life examples of impact of irrational prescription have potential to improve prescribing practices....
3.
Koyani H, Vora N, Kalathia M, Patel N, Shah S
Cureus
. 2023 Feb;
15(1):e33739.
PMID: 36793848
Introduction Drug utilization research (DUR) is "the marketing, distribution, prescription, and use of drugs in a society, with special emphasis on the resulting medical, social, and economic consequences" as per...
4.
Chauhan N, Desai M, Shah S, Shah A, Gadhavi R
Perspect Clin Res
. 2021 Apr;
12(1):40-47.
PMID: 33816208
Objective: The objective of the study was to compare the maternal and fetal outcomes of currently preferred tenofovir-based regimen with previous zidovudine-based regimen and also to determine whether the time...
5.
Modi A, Desai M, Shah S, Shah B
Indian J Dermatol
. 2019 Jun;
64(3):250.
PMID: 31148872
Introduction: Skin is one of the major target organ for adverse drug reactions (ADRs). The incidence of dermatological ADRs among indoor patients in developed countries ranges from 1-3%, whereas in...
6.
Amin S, Shah S, Desai M, Shah A, Maheriya K
Perspect Clin Res
. 2018 Jun;
9(2):70-75.
PMID: 29862199
Objectives: To analyze clinical spectrum, seriousness, outcome, causality, severity and preventability of ADRs in geriatrics and pediatric patients. Materials And Methods: All ADRs reported in geriatrics (≥ 65 years) and...
7.
Prajapati K, Desai M, Shah S, Choudhary S, Aggarwal R, Mishra V
J Pharmacol Pharmacother
. 2017 Oct;
8(3):116-121.
PMID: 29081619
Objective: To compare different treatment regimens on pregnancy rate and outcome in patients with anovulatory infertility. Patients And Methods: A prospective observational study was conducted on patients with infertility due...
8.
Prajapati K, Shah S, Desai M
J Clin Diagn Res
. 2017 Feb;
10(12):FC36-FC39.
PMID: 28149832
Introduction: Fixed Dose Combinations (FDCs) are being increasingly used to improve compliance and achieve greater benefits of the two or more active ingredients given together than the corresponding individual drug...
9.
Prajapati K, Desai M, Shah S, Panchal J, Kapadia J, Dikshit R
Perspect Clin Res
. 2016 Nov;
7(4):181-186.
PMID: 27843794
Objective: The objective of this study was to analyze the various aspects of serious adverse drug reactions (serious ADRs) such as clinical presentation, causality, severity, and preventability occurring in a...
10.
Kapadia J, Shah S, Desai C, Desai M, Patel S, Shah A, et al.
Indian J Pharmacol
. 2013 May;
45(2):191-2.
PMID: 23716900
Tenofovir was introduced as a second line drug for the treatment of human immunodeficiency virus (HIV) infection in India in December 2009. Although rare, renal toxicity is a recognized adverse...